Phoenix PharmaLabs

Phoenix PharmaLabs

UT - Woods Cross
Biotechnology2 H-1B visas (FY2023)

Focus: Opiate Addiction Treatments

Phoenix PharmaLabs is a life sciences company focused on Opiate Addiction Treatments.

ImmunologyRespiratoryOncologyNeurologyHematology
Funding Stage
PRIVATE
Employees
5000+
Open Jobs
0
Interview Prep Quick Facts
Portfolio: 6 approved products
Top TAs: Immunology, Neurology, Respiratory
H-1B (2023): 2 approvals
Portfolio Health
Pre-Launch4 (67%)
Post-LOE2 (33%)
6 total products
Therapeutic Area Focus
Immunology
1 marketed
Neurology
1 marketed
Respiratory
1 marketed
Marketed
Pipeline

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
2
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub